M 4 E Common Technical Document for the …
© emea 2006 3 common technical document for the registration of pharmaceuticals for human use: efficacy clinical overview and clinical summary of module 2
Download M 4 E Common Technical Document for the …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Opinion of the Scientific Committee on Consumer …
ec.europa.euSCCP/0873/05 Opinion on the safety evaluation of parabens 5 3.1.2. The European Food Safety Authority (EFSA), EFSA 2004 a) Newly available studies on the developmental toxicity of methyl paraben in rats, mice,
Questions & Answers: positions on specific …
www.ema.europa.euReasoning . Requirements for food interaction studies for modified release formulations : July 2015 . Covered by the revised Guideline on …
Nutrition and food systems
www.fao.org2 . HLPE Reports series #1 Price volatility and food security (2011) #2 Land tenure and international investments in agriculture (2011) #3 Food security and …
Public Law 110–85 110th Congress An Act
www.gpo.govPUBLIC LAW 110–85—SEPT. 27, 2007 121 STAT. 823 Public Law 110–85 110th Congress An Act To amend the Federal Food, Drug, …